Table 4 Enriched pathways of Liu-wei-di-huang genes and Liu-wei-di-huang-treated disease genes identified by DAVID
Category | Enriched KEGG pathway | False discovery rate |
|---|---|---|
Liu-wei-di-huang genes | hsa05200:Pathways in cancer | 1.82E-06 |
hsa05014:Amyotrophic lateral sclerosis | 3.82E-06 | |
hsa04620:Toll-like receptor signaling pathway | 6.42E-06 | |
hsa04660:T cell receptor signaling pathway | 1.56E-05 | |
hsa04210:Apoptosis | 8.13E-04 | |
hsa04621:NOD-like receptor signaling pathway | 0.002737 | |
hsa05222:Small cell lung cancer | 0.00471 | |
hsa04080:Neuroactive ligand-receptor interaction | 0.007635 | |
hsa05210:Colorectal cancer | 0.03486 | |
Liu-wei-di-huang-treated | hsa05200:Pathways in cancer | 2.35E-12 |
disease genes | hsa05210:Colorectal cancer | 1.11E-07 |
hsa05221:Acute myeloid leukemia | 2.58E-07 | |
hsa05213:Endometrial cancer | 5.92E-07 | |
hsa05220:Chronic myeloid leukemia | 9.79E-05 | |
hsa05215:Prostate cancer | 1.38E-04 | |
hsa04930:Type II diabetes mellitus | 2.25E-04 | |
hsa05218:Melanoma | 3.68E-04 | |
hsa05216:Thyroid cancer | 0.002937 | |
hsa05214:Glioma | 0.005064 | |
hsa05223:Non-small cell lung cancer | 0.008102 | |
hsa04950:Maturity onset diabetes of the young | 0.01155 | |
hsa05212:Pancreatic cancer | 0.019292 |